Furthermore, within this large dataset, we found that Six1 correlates with shortened relapse free survival when examining all breast cancers (Figure 1B), but that this correlation is caused primarily by the effect of Six1 in the luminal breast cancer subtypes, particularly the luminal B subtype (Figure 1B). Here, SIX1 is linked to breast cancer.